Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Five Iron Golf Signs Largest Franchise Deal to Date, Adding 12 Locations in Florida from Miami to Jacksonville
-
Consensus estimates ahead of Q4 2024
-
Requite Unveils Tap ‘n Tip, Empowering Service Workers benefiting from Trump’s Tax-Free Tips Proposal
-
Actelis Networks Secures a Significant Order Ahead of Expected Next Phase of NRTS, Positioning the Company for Major Future Opportunities
-
AITX Subsidiary RAD-R Announces Expanded RADCam Benefits Including Alexa & Google Home Integration, Bringing Smarter Security to Homes Everywhere
-
AITX Subsidiary RAD-R Announces Expanded RADCam Benefits Including Alexa & Google Home Integration, Bringing Smarter Security to Homes Everywhere
-
Oxbridge Approves Bitcoin and Ethereum as Treasury Reserve Assets
-
VCI Global Secures US$100 Million in Funding Commitment to Fuel Further Growth in the AI and Renewable Energy Sector
-
American Battery Technology Company Commences New Drill Program to Accelerate Commercialization of Nevada Lithium Project to Support Call to Restore American Mineral Dominance
-
Cibus, Inc. Announces $22.6 Million Registered Direct Offering Priced Above Nasdaq’s Minimum Price in Accordance with Nasdaq Rules
-
Solid Biosciences Receives FDA Fast Track Designation for SGT-212 Dual Route of Administration Gene Therapy for Friedreich’s Ataxia
-
CourseCompare Names Canada’s Top Schools in 2025 Rankings Amid Shifting Enrollment and Lagging Productivity
-
Kane to Host Investor Webinar – What Kane has in Store for 2025 Including the Acquisition of FB Dermatology
-
Safe & Green Holdings Corp. Announces Appointment of Jim Pendergast as Chief Operating Officer
-
Verb’s ‘Go Fund Yourself’ Groundbreaking New Crowd-Funding TV Show Announces Expansive TV Distribution Deal With Cheddar
-
Bluejay Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for Brelovitug (BJT-778) for the Treatment of Chronic Hepatitis Delta
-
KULR Expands Bitcoin Holdings to 510 BTC, Reports 127% BTC Yield
-
Myriad Genetics Announces Hereditary Cancer Risk Assessment Program Study Published in Obstetrics & Gynecology
-
The Blood Connection Expands Reach by Delivering Lifesaving Blood Products to UVA Health University Medical Center
-
Imagining the Future: Payden & Rygel Takes an Unconventional
-
Celestica Recognized as One of Canada’s Top Employers for Young People for the Second Consecutive Year
-
Alico, Inc. to Present at Sidoti Micro-Cap Virtual Conference
-
Worksport Ltd. ($WKSP) Announces Strong Q4 2024 Results, Beating Revenue Guidance; Recording a Substantial December Gross Margin increase
-
Prenetics Unveils IM8 to U.S. Consumers with Co-Founding Partner David Beckham
-
Ormat Technologies, Inc. to Host Conference Call Announcing Fourth Quarter and Year End 2024 Financial Results
-
Vemanti Group Announces Discussions Regarding Onus Finance UAB
-
HYCU® R-Cloud™ Named to TechTarget Storage Products of the Year Awards
-
NewtekOne, Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on Wednesday, February 26, 2025, After the Market Closes
-
D. Boral Capital Secures Strategic Investments from Global Investment Bank ARC Group and an Institutional Investor
-
Nascent Biotech Receives Delinquency Notification Related to its Delayed September 30, 2024 Financial Filing
-
Blüm Holdings, Inc. Announces Strategic Financing and Intended Acquisitions
-
Adaptive Research Expands into Psychiatry with Addition of Prodigy Psychiatric Group to Clinical Trial Network
-
Corrections - Philux Global Group to Expedite Closings of Largest Financing Transactions
-
Safe & Green Holdings Corp. Announces Appointment of Jim Pendergast as Chief Operating Officer
-
Virco Adopts New Share Repurchase Program
-
Orennia completes Series C funding led by Decarbonization Partners
-
Microbot Medical® Strengthens Its Management Team in Support of the Anticipated Commercial Launch of LIBERTY®
-
Proximic by Comscore Releases 2025 State of Programmatic Report
-
Berry Corporation Announces Finance Team Leadership Changes
-
Myriad Genetics Announces Hereditary Cancer Risk Assessment Program Study Published in Obstetrics & Gynecology
-
Imagining the Future: Payden & Rygel Takes an Unconventional
-
Janover Announces 190%+ Growth of AI Enabled Software Business
-
Thea Energy Announces New Headquarters to Support Core Technology Development and Manufacturing
-
Byrna Technologies to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results on Friday, February 7, 2025 at 9:00 a.m. ET
-
Vornado Realty Trust Becomes First in Nation to Achieve LEED Certification Across Entire In-Service Portfolio
-
Middlefield Canadian Income PCC: Net Asset Value(s)
-
Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Launched FIRDAPSE® in Japan
-
IREN Business Update
-
Lever Student Loans Redefines Debt Management for a Bold New Era
-
Jeffs' Brands Provides Update Regarding Potential Acquisition of its U.S. Subsidiary, for an Approximate Valuation of USD $11.8 million to a Canadian Public Company
